Older women with early-stage breast cancer face significant cardiovascular mortality risk, highlighting the need for effective cardiovascular preventive therapy.
Cardiovascular death is a significant competing risk in older women with early-stage breast cancer, highlighting the need for cardiovascular preventive therapy.
Cardiovascular death is an important competing risk for older women with early-stage breast cancer. This finding mandates adequate attention to cardiovascular preventive therapy after diagnosis of breast cancer.
Abdel‐Qadir et al. (2016) studied this question. Older women with early-stage breast cancer face significant cardiovascular mortality risk, highlighting the need for effective cardiovascular preventive therapy.